Intermediate risk prostate cancer. Evaluate extent of disease. PELVIS:PROSTATE:Prostate Size: 3.3 x 5.3 x 4.7 cmPeripheral Zone: In the left mid gland/apex there is a 1.6 x 0.9 x 1.1 cm lesion demonstrating T2-weighted hypointensity (series 901/9), restricted diffusion (series 704/ 224) and early enhancement with washout (series 1701/1211).Central Gland: Changes of BPH.Seminal Vesicles: No evidence of seminal vesicle invasion.Extracapsular Extension: The left mid gland/apex lesion broadly abuts the fibromuscular capsule and bulges it suspicious for extraprostatic extension.BLADDER: No significant abnormality noted.LYMPH NODES: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1.6 cm left mid gland/apex lesion with broad abutment and bulging of the adjacent capsule suspicious for extraprostatic extension. No pelvic lymphadenopathy.